UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000022256
Receipt No. R000024427
Scientific Title A multicenter, cooperative, randomized, comparative study regarding the efficacy of denosumab for bone loss related to postoperative endocrine therapy in postmenopausal patients with hormone-sensitive breast cancer
Date of disclosure of the study information 2016/07/01
Last modified on 2020/05/27 10:44:11

No. Disposal Last modified on Item of update
1 Insert 2016/05/10 00:59:13
2 Update 2016/11/23 19:40:07 Date of protocol fixation
Anticipated trial start date
3 Update 2016/11/23 19:53:06 Key inclusion criteria
Key inclusion criteria
4 Update 2016/11/23 20:04:38 Organization
Organization
Organization
Institute
Co-sponsor
Co-sponsor
Institutions
5 Update 2017/05/16 07:23:28 Public title
Acronym
6 Update 2017/05/16 07:40:31 Narrative objectives1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
7 Update 2017/05/16 08:12:43 Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
8 Update 2017/05/16 08:30:45 Organization
Organization
Institute
Department
Institutions
9 Update 2017/05/16 08:34:46 Recruitment status
Date of protocol fixation
Anticipated trial start date
10 Update 2018/05/11 11:15:49 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
11 Update 2020/05/26 15:01:55 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email
Email
Organization
Organization
Address
Address
Tel
Email
12 Update 2020/05/26 16:28:49 Email
13 Update 2020/05/26 16:29:40 UMIN ID1
14 Update 2020/05/27 10:29:39 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
15 Update 2020/05/27 10:44:11 Co-sponsor
Co-sponsor
Organization1
Institutions


Contact us.